Evidence map›Paper›PMID 29720498›Full record

ArticleDiabetes2018

Altered Extracellular Vesicle Concentration, Cargo, and Function in Diabetes.

David W Freeman, Nicole Noren Hooten, Erez Eitan, Jamal Green, Nicolle A Mode, Monica Bodogai, Yongqing Zhang, Elin Lehrmann, Alan B Zonderman, Arya Biragyn and 5 more

Registry-linked trialAbstract read
In one paragraph

Article in Diabetes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04164966 (Development of Novel Biomarkers for the Early Diagnosis of Type 1 Diabetes), which is not on this map. Cited by 165 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
165citing papers in PubMed, 2 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04164966 active not recruitingnot on this mapstarted 2019, after this paper: background citation

Development of Novel Biomarkers for the Early Diagnosis of Type 1 Diabetes

TypeobservationalSponsorAdventHealth Translational Research InstituteRan2019 to 2026Enrolled28ConditionsType 1 Diabetes
3 · Its place in the literature

Who cites it

165 citing papers in PubMed, 2 syntheses or guidelines pooled it, 246 citations in OpenAlex.

  1. Pooled it
  2. Type 2 Diabetes: How Much of an Autoimmune Disease?Frontiers in endocrinology · 2019
    Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Adipose-Derived Extracellular Vesicles and Intercellular Crosstalk With Skeletal Muscle: Implications for Sarcopenic Obesity and Metabolic Dysregulation.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Review

105 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

David W FreemanLaboratory of Epidemiology and Population Science, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Nicole Noren HootenLaboratory of Epidemiology and Population Science, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Erez EitanLaboratory of Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Jamal GreenLaboratory of Epidemiology and Population Science, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Nicolle A ModeLaboratory of Epidemiology and Population Science, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Monica BodogaiLaboratory of Molecular Biology and Immunology, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Yongqing ZhangLaboratory of Genetics and Genomics, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Elin LehrmannLaboratory of Genetics and Genomics, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Alan B ZondermanLaboratory of Epidemiology and Population Science, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Arya BiragynLaboratory of Molecular Biology and Immunology, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Josephine EganLaboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Kevin G BeckerLaboratory of Genetics and Genomics, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Mark P MattsonLaboratory of Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Ngozi EjioguLaboratory of Epidemiology and Population Science, National Institute on Aging, National Institutes of Health, Baltimore, MD.
Michele K EvansLaboratory of Epidemiology and Population Science, National Institute on Aging, National Institutes of Health, Baltimore, MD me42v@nih.gov.ORCID 0000-0002-8546-2831
National Institutes of Health · US

Funding

Healthy Aging In Neighborhoods of Diversity Across the Life Span (HANDLS)ZIAAG000513 · NIA · NATIONAL INSTITUTE ON AGING · PI EVANS, MICHELE K · 2009 to 2025
$70.9M
The Underlying Biology of Health DisparitiesZIAAG000519 · NIA · NATIONAL INSTITUTE ON AGING · PI EVANS, MICHELE K · 2009 to 2025
$15.7M
Analysis of complex biological systems by microarray based gene expressionZICAG000616 · NIA · NATIONAL INSTITUTE ON AGING · PI DE, SUPRIYO · 2009 to 2025
$15.5M
Novel immunotherapeutic strategies to treat cancer and diseases of old peopleZIAAG000770 · NIA · NATIONAL INSTITUTE ON AGING · PI BIRAGYN, ARYA · 2009 to 2025
$13.0M
The role of immunosuppressive cells in metastasisZIAAG000443 · NIA · NATIONAL INSTITUTE ON AGING · PI BIRAGYN, ARYA · 2009 to 2022
$8.6M
Characterization of Serum Extracellular Vesicles with Human AgeZIAAG000989 · NIA · NATIONAL INSTITUTE ON AGING · PI EVANS, MICHELE K · 2017 to 2025
$4.1M
Measuring DNA Damage/Repair Capacity in Human PopulationZ01AG000519 · NIA · NATIONAL INSTITUTE ON AGING · PI EVANS, MICHELE K · 2005 to 2008
$942k
PERIPHERAL NEUROPATHY, SENSORIMOTOR FUNCTIONS &BALANCEK23AG000989 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RICHARDSON, JAMES K · 2000 to 2004
$711k
Intramural NIH HHS Z01 AG000519NIA NIH HHS K23 AG000989
6 · The paper itself

Abstract

Type 2 diabetes is a chronic age-associated degenerative metabolic disease that reflects relative insulin deficiency and resistance. Extracellular vesicles (EVs) (exosomes, microvesicles, and apoptotic bodies) are small (30-400 nm) lipid-bound vesicles capable of shuttling functional proteins, nucleic acids, and lipids as part of intercellular communication systems. Recent studies in mouse models and in cell culture suggest that EVs may modulate insulin signaling. Here, we designed cross-sectional and longitudinal cohorts of euglycemic participants and participants with prediabetes or diabetes. Individuals with diabetes had significantly higher levels of EVs in their circulation than euglycemic control participants. Using a cell-specific EV assay, we identified that levels of erythrocyte-derived EVs are higher with diabetes. We found that insulin resistance increases EV secretion. Furthermore, the levels of insulin signaling proteins were altered in EVs from individuals with high levels of insulin resistance and β-cell dysfunction. Moreover, EVs from individuals with diabetes were preferentially internalized by circulating leukocytes. Cytokine levels in the media and in EVs were higher from monocytes incubated with diabetic EVs. Microarray of these leukocytes revealed altered gene expression pathways related to cell survival, oxidative stress, and immune function. Collectively, these results suggest that insulin resistance increases the secretion of EVs, which are preferentially internalized by leukocytes, and alters leukocyte function.

Indexed as

AdultAgedCytokinesDiabetes Mellitus, Type 2Extracellular VesiclesFemaleHumansInsulin ResistanceInsulin-Secreting CellsMaleMiddle AgedCytokines

Identifiers

PMID29720498
PMCPMC6198336
OpenAlexW2800208504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.